Trial Information
Current as of November 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is trying to see if simple text message reminders to parents can help pull up vaccination rates for young children. It focuses on kids aged 0-2 in Sunset Park, Brooklyn who are behind on vaccines and receive care at NYU Langone Health’s Brooklyn Family Health Centers. Eligible children are 1 to 2 years old, must be in the NYU Brooklyn clinic network, and have vaccines due or due soon. Families are invited to join, and kids outside this age or outside the network aren’t eligible.
Participants are put into one of three groups: text message 1 (safety and clinic cleanliness framing), text message 2 (importance of vaccines framing), or no text message. Over about a year, researchers will look at changes in how many vaccines are given (the proportion of due vaccines that get completed) and how many vaccination appointments are scheduled. The study began in 2021, plans to enroll about 1,203 children, and aims to finish around March 2026. It’s an observational, non-drug study led by NYU Langone Health, not regulated by the FDA, and individual results aren’t shared beyond the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children ages 0-2 years with delayed vaccinations (due for vaccine and due soon) in NYU Brooklyn Family Health Centers network.
- Exclusion Criteria:
- • Children above the age of 2 who do not attend NYU Brooklyn Family Health Centers network
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Holly Krelle
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials